Mortgage Blog
Veterinary telehealth startup Felix&Fido launches with $4M in funding
The Issaquah-based startup is launching with service in a number of Eastside towns and plans to open its first clinic in May.
Former Whole Foods execs incorporate Longmont telehealth company in new startup
The new business touts itself as an “integrated wellness solution” that unites nutrition, holistic care and wellness therapies to promote healthy living and communities.
What’s changing the way wealth changes hands? Advisers weigh in.
With the great wealth transfer on the horizon, wealth advisers and related professionals weigh in on how their clients' priorities are shifting.
PNC invests 40% of $88B Community Benefits Plan in 2022, its first year
Four-year national initiative debuted Jan. 1, 2022.
Boulder’s DeathApp is trying to take the fear out of death planning
“The only guarantee in life is that it will end,” is the tagline used by a new Boulder startup that aims to engage younger generations in estate planning by making the subject of death less taboo.
A group of technology and finance professionals — most of them in Boulder — teamed up with an end-of-life chaplain to incorporate Exit Plan Inc. in December. The group has since launched a beta version of its mobile application, and it's raising money to design and develop a fuller prototype.
The…
Gilead drops option to buy cancer therapeutics company
The reworked deal frees Gilead's South San Francisco partner to reach out to new sources of cash and collaborations.
Baptist Health, Encompass Health break ground on $44M hospital
Work started on the roughly 48,000-square-foot joint facility, and it is expected to be completed in the summer of 2024.
Viewpoint: Clinical trial hub benefits every level of society
Southern Research’s newly proposed Community Health Catalyst platform would enable providers to bring medical care to Alabama residents by giving them information about clinical trials that would meet their unique health care needs.
Moleculin enters Phase 2 clinical trials, reports bigger net loss in 2022 year-end results
Moleculin is pushing its chemotherapy drug Annamycin into a second phase of clinical trials, with officials confident its data can lead to FDA approval.
‘Great parts of the business’: Stifel hires former Silicon Valley Bank senior managers
Stifel said the three new hires played no role in the March 10 collapse of Silicon Valley Bank. That occurred on the treasury side of the bank, which used excess deposits to invest in long-term Treasurys and other government-sponsored debt securities.